CFTR and cystic fibrosis: Current CF therapies fall in two categories: symptomatic treatments, consisting in the administration of aggressive antibiotics, osmotic agents and pancreatic enzyme products and systematic treatments, consisting in the administration of CFTR modulators able to improve the deficient or defective activity of the mutated CFTR by either restore its trafficking (correctors) or gating (potentiators) [16].